Amplity proudly announces the launch of Ava, an AI-powered chatbot designed to deliver faster, more personalized digital experiences on Amplity.com.
Ava—short for AI Virtual Assistant—was named through an employee contest, with several team members independently submitting the winning suggestion. Chosen for its simplicity, memorability, and alignment with Amplity’s dynamic new brand,...
Comprehensive suite of solutions designed to empower oncology care teams, accelerating patient diagnosis and treatment
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced the launch of the Viz Oncology™ Suite, a transformative platform designed to accelerate access to life-saving cancer care. This marks a strategic expansion...
BRANY announces the launch of Protocol Builder® 2.0, an advanced cloud-based tool for protocol writing, now enhanced with AI capabilities. Building on a decade of success, Protocol Builder has been widely used by institutions, biotech firms, and pharmaceutical companies.
Revolutionizing Research Protocol Development with AI
Protocol Builder 2.0 helps investigators develop comprehensive research...
Collaboration will extend work to prioritize valuable novel target-effector pairs, ideal for subsequent molecular glue development, including aiming at targets previously considered undruggable through conventional methods
VantAI, a leader in generative AI and proximity-based therapeutics, announced that it has entered into a second expansion of its collaboration and license agreement...
Elemental Machines, a pioneer in intelligent lab operations solutions, announced the expansion of its partnership as a Gold Sponsor with LabCentral, a premier launchpad for high-potential life sciences and biotech startups.
As part of the partnership, Elemental Machines will continue to provide its Intelligent Operations Platform and validated hardware integrations across LabCentral’s flagship...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced a multi-year partnership with Sanofi, an innovative global healthcare company, and Regeneron, a leading biotechnology company, to deploy and evaluate an AI-powered workflow solution for chronic obstructive pulmonary disease (COPD). With support from Sanofi and Regeneron, Viz.ai...
Basil Systems, the leading AI-powered product lifecycle intelligence platform for the life sciences industry, announced the launch of Insights, a powerful new feature within its Basil Intel for Pharma platform. The new tool transforms how pharmaceutical teams analyze global drug labels, delivering structured, AI-generated comparisons in seconds that streamline regulatory compliance,...
Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), announced the launch of its innovative Cloud Lab platform following the successful closure of an oversubscribed $12 million Series A financing round. The new platform allows pharmaceutical companies to develop formulations using Persist...
Redica Systems, a leader in Quality and Regulatory Intelligence for the Life Sciences industry, announced a financing with participation by Merck Global Health Innovation Fund (MGHIF) along with existing investors Savant Growth and Rock Creek Capital.
The investment will accelerate Redica’s expansion of its Catalyst Platform™ and the Redica Supplier Data Network™ (SDN),...
Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases
QIAGEN announced it has signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.
The acquisition adds Franklin, Genoox’s flagship...
